AMERICAN EXPRESS CO·4

May 7, 4:25 PM ET

Young Christopher David 4

4 · AMERICAN EXPRESS CO · Filed May 7, 2026

Research Summary

AI-generated summary of this filing

Updated

American Express Director Christopher Young Receives 742 SEUs

What Happened

  • Christopher David Young, a director of American Express Company (AXP), received a grant of 742.115 share-equivalent units (SEUs) on 2026-05-05. The units were reported at $0.00 per unit (no cash paid) and are recorded as a derivative award (transaction code A) on the Form 4 filed 2026-05-07. This is a compensation grant (not a market purchase or sale) and is routine director deferred compensation.

Key Details

  • Transaction date: 2026-05-05; Form 4 filed: 2026-05-07 (filed within the normal 2-business-day window).
  • Award: 742.115 share-equivalent units; reported price: $0.00 (cashless grant).
  • Shares/units owned after transaction: Not reported on the Form 4.
  • Footnotes: SEUs reflect the value of one common share (F1); units were granted under the Directors' Deferred Compensation Plan and will be settled in cash after termination of service (F2); units are convertible immediately upon termination and have no expiration date (F3).

Context

  • These SEUs are a deferred, cash-settled form of director compensation, not an outright stock purchase or stock sale. Such grants are common for non-employee directors and do not, by themselves, indicate buying or selling sentiment in the market.

Insider Transaction Report

Form 4
Period: 2026-05-05
Transactions
  • Award

    Share Equivalent Units

    [F1][F2][F3]
    2026-05-05+742.11520,811.843 total
    Common Stock (742.115 underlying)
Footnotes (3)
  • [F1]Each Share Equivalent Unit reflects the value of one common share.
  • [F2]The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director.
  • [F3]The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date.
Signature
/s/ James J. Killerlane III, attorney-in-fact|2026-05-07

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT